BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Diagnosis
23 results:

  • 1. Recurrence Patterns and Surveillance Imaging in Pediatric brain Tumor Survivors.
    Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis.
    Zhuang G; Zhang X; Du W; Xu L; Ma J; Luo H; Tang H; Wang W; Wang P; Li M; Yang X; Wu D; Fang S
    J Transl Med; 2024 Jan; 22(1):65. PubMed ID: 38229122
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Automated brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
    Gutsche R; Lowis C; Ziemons K; Kocher M; Ceccon G; Régio Brambilla C; Shah NJ; Langen KJ; Galldiks N; Isensee F; Lohmann P
    J Nucl Med; 2023 Oct; 64(10):1594-1602. PubMed ID: 37562802
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors.
    Godlewski A; Czajkowski M; Mojsak P; Pienkowski T; Gosk W; Lyson T; Mariak Z; Reszec J; Kondraciuk M; Kaminski K; Kretowski M; Moniuszko M; Kretowski A; Ciborowski M
    Sci Rep; 2023 Jul; 13(1):11044. PubMed ID: 37422554
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).
    Merollini KMD; Gordon LG; Ho YM; Aitken JF; Kimlin MG
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954835
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review.
    Wei LD; Li C; Li D; Liu XJ; Li RT; Li LW; Wang JM; Zhou DB
    Pituitary; 2021 Oct; 24(5):754-767. PubMed ID: 33982223
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
    Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
    World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
    Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN
    J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival Analysis of Glioblastoma Multiforme.
    Witthayanuwat S; Pesee M; Supaadirek C; Supakalin N; Thamronganantasakul K; Krusun S
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2613-2617. PubMed ID: 30256068
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anxiety, memories and coping in patients undergoing intracranial tumor surgery.
    van Ark TJ; Klimek M; de Smalen P; Vincent AJPE; Stolker RJ
    Clin Neurol Neurosurg; 2018 Jul; 170():132-139. PubMed ID: 29793130
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
    Cennamo G; Auriemma RS; Cardone D; Grasso LF; Velotti N; Simeoli C; Di Somma C; Pivonello R; Colao A; de Crecchio G
    Eye (Lond); 2015 Jun; 29(6):797-802. PubMed ID: 25853400
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The age peculiarities of metabolism and structure of the brain tumors and its clinical significance].
    Rozumenko VD; Iavorskiĭ AA; Malysheva TA; Vaslovich VV; Chernenko OG; Bobrik IS
    Klin Khir; 2014 Nov; (11):48-51. PubMed ID: 25675745
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Economic burden associated with adverse events in patients with metastatic melanoma.
    Arondekar B; Curkendall S; Monberg M; Mirakhur B; Oglesby AK; Lenhart GM; Meyer N
    J Manag Care Spec Pharm; 2015 Feb; 21(2):158-64. PubMed ID: 25615005
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Stereotactic radiosurgical salvage treatment for locally recurrent esthesioneuroblastoma.
    Van Gompel JJ; Carlson ML; Pollock BE; Moore EJ; Foote RL; Link MJ
    Neurosurgery; 2013 Mar; 72(3):332-9; discussion 339-40. PubMed ID: 23208068
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.
    Cronin-Fenton DP; Søndergaard F; Pedersen LA; Fryzek JP; Cetin K; Acquavella J; Baron JA; Sørensen HT
    Br J Cancer; 2010 Sep; 103(7):947-53. PubMed ID: 20842120
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
    Dimaraki EV; Jaffe CA; DeMott-Friberg R; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3537-42. PubMed ID: 12161471
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
    Sneed PK; Lamborn KR; Forstner JM; McDermott MW; Chang S; Park E; Gutin PH; Phillips TL; Wara WM; Larson DA
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):549-58. PubMed ID: 10078636
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Stereotactic radiosurgery for brain metastases: comparison of lung carcinoma vs. non-lung tumors.
    Williams J; Enger C; Wharam M; Tsai D; Brem H
    J Neurooncol; 1998 Mar; 37(1):79-85. PubMed ID: 9525842
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
    Carvlin MJ; De Simone DN; Meeks MJ
    Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.